Revenue: The sum of all revenue fields included for a company's operating activities.
Revolution Medicines, Inc. (RVMD) had Revenue of $0.74M for the most recently reported fiscal quarter, ending 2023-12-31.
| Income Statement Financials | |
|
Revenue |
$0.74M |
$-161.54M |
|
-- |
|
$0.74M |
|
$180.72M |
|
$-179.98M |
|
$18.79M |
|
$-161.19M |
|
$-161.19M |
|
$-161.54M |
|
$-161.54M |
|
$-161.54M |
|
$-161.54M |
|
$-179.98M |
|
$-185.76M |
|
113.15M |
|
113.15M |
|
$-1.23 |
|
$-1.23 |
|
| Balance Sheet Financials | |
$1.88B |
|
$22.86M |
|
$182.42M |
|
$2.06B |
|
$143.85M |
|
-- |
|
$91.66M |
|
$235.51M |
|
$1.83B |
|
$1.75B |
|
$1.83B |
|
164.68M |
|
| Cash Flow Statement Financials | |
$-350.57M |
|
$-342.60M |
|
$1.23B |
|
$163.15M |
|
$699.18M |
|
$536.03M |
|
$61.77M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
13.06 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-24256.47% |
|
-24256.47% |
|
-- |
|
-21724.26% |
|
-21770.48% |
|
$-358.30M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
0.59 |
|
152.10 |
|
-8.85% |
|
-9.21% |
|
-7.84% |
|
-8.85% |
|
$11.09 |
|
$-3.17 |
|
$-3.10 |
|